An observational study in Healthy Aging, Sarcopenia and Frailty, sponsored by National Health Research Institutes, Taiwan. Recruiting at 1 site in Taiwan. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by National Health Research Institutes, Taiwan · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Sarcopenia with a site in Taiwan — 30 open to participants now, 31 under way, none of them phase 3. Sarcopenia · Taiwan.
Among the 96 studies in Sarcopenia with a site in Taiwan, this one has the largest planned enrollment of the 29 observational ones that give a count, is one of 11 that started in 2025, is one of 29 observational ones, reaches primary completion later than 29 of the 30 other live ones, and was the 76th registered.
1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.
Browse Sarcopenia studies →30 of the 96 studies in Sarcopenia with a site in Taiwan are open now. Recruiting first, the newest first:
Taipei Medical University Hospital · Sites in Taiwan
Ages 60+
Tzu Chi University · Sites in Taiwan
Ages 65–100 · Healthy volunteers
yueh chu wu · Sites in Taiwan
Ages 45–85
Valeria Chiu · Sites in Taiwan
Ages 18+ · Women only
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 50–99
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.
This study: 40 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 11 started in 2025.
This study's planned enrollment of 5,000 is above the median of 120 across 455 observational studies indexed under Sarcopenia.
Median enrollment 80 across the 67 interventional studies, 151 across the 29 observational. Of the 51 that completed or were terminated, 4 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 96 have an industry lead sponsor. The 10 most frequent:
National Health Research Institutes, Taiwan is the lead sponsor of 129 studies on the registry; 31 are open to participants now.
National Health Research Institutes, Taiwan has 1 study filed under Sarcopenia — fewer than ten, so there is no comparison to draw.
7 of the studies in Sarcopenia with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07830472Taipei Medical University HospitalLower-Limb Rehabilitation Robot Training for Sarcopenia | 2026-12 |
| NCT02635022National Taiwan University HospitalFragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study | 2026-12 |
| NCT07815158National Yang Ming Chiao Tung UniversityMulti-Component Nutrition, Intrinsic Capacity, and Physical Function in Older Adults | 2026-12-15 |
| NCT07726758Tzu Chi UniversityThe Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults | 2026-12-31 |
| NCT07465393Valeria ChiuFacility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 96 studies in Sarcopenia with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective study investigates the health effects of vegetarian and plant-based diets in middle-aged and older adults in Taiwan, specifically, recruiting 5000 Tzu Chi volunteers. Previous Tzu Chi cohorts found vegetarian diets were protectively associated with incidences of diabetes, stroke, gout, cataracts, insomnia, and gallstones, while reducing healthcare costs. The study also aims to clarify dietary patterns-particularly plant-based and vegetarian diets-and determine how potential deficiencies or excesses of various nutrients influence common aging-related health issues, including healthy cognitive decline, sarcopenia, and the risk of age-related diseases, in order to inform dietary and lifestyle recommendations that promote healthy aging and maintain physical function.
This study establishes a new cohort to investigate the role of vegetarian and plant-based diets in healthy aging, integrating functional, nutritional, and genetic data. The primary objective is to clarify how dietary patterns and nutrient intake influence aging-related health conditions, including sarcopenia, cognitive function, physical function, and psychological well-being, and investigate how the associations between diet and these health conditions may be modified by genetic risk factors.
Participants are Tzu Chi volunteers aged 40 years and older who undergo comprehensive health evaluations at Dalin Tzu Chi Hospital every three years. This population consists of a uniquely high proportion of vegetarians, non-smoking non-alcohol drinking individuals, and older adults who are active in communities and social engagement and community services; providing a unique opportunity to examine the role of plant-based diets and community services on aging related conditions without confounding by smoking and alcohol. Diet data are collected through a previously validated food frequency questionnaire, a short newly developed questionnaire - Taiwan Diet Quality Calculator - that will be validated within a subcohort of the current study, and food diaries for participants who are willing to provide such details. Nutritional biomarkers (e.g., serum vitamin B12, vitamin D, skin carotenoids), along with routine health examination values (complete blood counts, lipid profiles, renal and liver functions, bone mineral density) will also be collected. When funding permits, genome-wide genotyping, metabolomics, and other aging-related biomarkers will also be examined.
For cohort follow-up, study participants will be invited back for follow-up health examination every three years. In addition, data will also be linked to National Health Insurance Claim database, National Cancer registry, and National Mortality Registry in Taiwan to further ascertain relevant health outcomes.
By integrating comprehensive dietary assessments, nutritional biomarkers, health examination and genetic data, and aging-related functional outcomes, this cohort will provide an unique opportunity to examine dietary patterns, nutrient requirements, and lifestyle that best support healthy aging. The inclusion of genomic and metabolomic analyses will further enable the investigation of diet-gene interactions, supporting the development of precision nutrition strategies for individuals at elevated genetic risk. This research is expected to inform strategies for disease prevention and the maintenance of functional independence in older adults.
Middle-aged and older adults (≥40 years) who are volunteers of the Tzu Chi Foundation or their relatives and friends, participating in the 2-day comprehensive health examination program in Taiwan.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cognitive Function
Cognitive function will be assessed using Montreal Cognitive Assessment \[MoCA\], Taiwanese version. (Score range 0-30, unit = points). A score ≥26 is generally considered normal, while scores \<26 suggest possible cognitive impairment. Outcomes will be reported both as continuous MoCA scores and as a binary classification (normal vs. impaired).
Time frame: From enrollment to three-year follow-up, six-year follow up
Appendicular skeletal muscle mass
Appendicular skeletal muscle mass (ASM) will be assessed by bioimpedance analysis (BIA), with height-adjusted cutoffs of \<7.0 kg/m² in men and \<5.7 kg/m² in women defined as low ASM. Results will be reported as both continuous measures (kg/m²) and categorical measures (normal or low ASM).
Time frame: From baseline to three-year follow-up, six-year follow-up
Grip strength
Grip strength will be assessed using a handheld dynamometer, with cutoffs defined as \<28 kg for men and \<18 kg for women. Results will be reported as continuous measures (kg).
Time frame: From baseline to three-year follow-up, six-year follow-up
Sarcopenia
Sarcopenia will be defined as the combined presence of low ASM and low grip strength. Results will be reported as a binary outcome (yes/no).
Time frame: From baseline to three-year follow-up, six-year follow-up
Plan to share: Undecided
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Dec 2028, 39 months after the start.
Of 192 non-industry observational studies under Sarcopenia, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 63. This study's planned 39 months is above that.
Counting every sponsor, half of 194 studies reached it within 26 months; a quarter within 12 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Health Research Institutes, Taiwan →